Sign In
Buy CDTX
$221.38
+0 (+0%)
At Close: Apr 07, 2026
Oppenheimer Keeps Their Buy Rating on Athenex (ATNX)
09:57pm, Wednesday, 22'nd Apr 2020
In a report released today, Kevin DeGeeter from Oppenheimer maintained a Buy rating on Athenex (ATNX – Research Report), with
Exact Sciences (EXAS) Gets a Buy Rating from Oppenheimer
12:31am, Wednesday, 22'nd Apr 2020
In a report released yesterday, Kevin DeGeeter from Oppenheimer assigned a Buy rating to Exact Sciences (EXAS), with a price target of $115.00. The
Exact Sciences (EXAS) Gets a Buy Rating from Oppenheimer
12:31am, Wednesday, 22'nd Apr 2020
In a report released yesterday,
Kevin DeGeeter
from Oppenheimer assigned a
Buy
rating to Exact Sciences (
EXAS
–
Research Report
), with a price target of
$115.00
. The company’s shares closed las
Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and Vascular Biogenics (VBLT)
03:11am, Friday, 17'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biogen (BIIB) and Vascular Biogenics (VBLT) with bullish
Analysts Offer Insights on Healthcare Companies: Biogen (NASDAQ: BIIB) and Vascular Biogenics (NASDAQ: VBLT)
03:11am, Friday, 17'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biogen (BIIB
Analysts Offer Insights on Healthcare Companies: Staar Surgical Company (STAA), Planet 13 Holdings (OtherPLNHF) and PolarityTE (PTE)
10:17am, Tuesday, 14'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Staar Surgical Company (STAA), Planet 13 Holdings (PLNHF)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Staar Surgical Company (
STAA
–
Research Report
), Planet 13 Holdings (
PLNHF
–
Research Report
) a
Oppenheimer Remains a Buy on Athenex (ATNX)
01:39pm, Thursday, 09'th Apr 2020
In a report released today, Kevin DeGeeter from Oppenheimer maintained a Buy rating on Athenex (ATNX), with a price target of $23.00. The company's shares
Oppenheimer Remains a Buy on Athenex (ATNX)
01:39pm, Thursday, 09'th Apr 2020
In a report released today, Kevin DeGeeter from Oppenheimer maintained a Buy rating on Athenex (ATNX – Research Report), with
Contrasting Cidara Therapeutics (NASDAQ:CDTX) and Audentes Therapeutics (NASDAQ:BOLD)
09:14am, Thursday, 09'th Apr 2020
Audentes Therapeutics (NASDAQ:BOLD) and Cidara Therapeutics (NASDAQ:CDTX) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of t
Novavax (NVAX) Received its Third Buy in a Row
01:29pm, Wednesday, 08'th Apr 2020
After Ladenburg Thalmann & Co. and Cantor Fitzgerald gave Novavax (NASDAQ: NVAX) a Buy rating last month, the company received another Buy, this time
Novavax (NVAX) Received its Third Buy in a Row
01:29pm, Wednesday, 08'th Apr 2020
After Ladenburg Thalmann & Co. and Cantor Fitzgerald gave Novavax (NASDAQ: NVAX) a Buy rating last month, the company received
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO) and PTC Therapeutics (PTCT)
10:14am, Wednesday, 08'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioNano Genomics (BNGO) and PTC Therapeutics (PTCT) with
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (NASDAQ: BNGO) and PTC Therapeutics (NASDAQ: PTCT)
10:14am, Wednesday, 08'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioNano Genomics
Cidara Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference
12:00pm, Tuesday, 07'th Apr 2020
SAN DIEGO, April 07, 2020 -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a clinical-stage biotechnology company focused on the discovery, development and commercialization of.
